A new self: MHC-class-I-independent Natural-killer-cell self-tolerance (original) (raw)

• Stetson, D. B. et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198, 1069–1076 (2003).
  CAS PubMed PubMed Central Google Scholar
• Tato, C. M. et al. Innate production of IFN-γ by NK cells is independent of epigenetic modification of the IFN-γ promoter. J. Immunol. 173, 1514–1517 (2004).
  CAS PubMed Google Scholar
• Walker, L. S. & Abbas, A. K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nature Rev. Immunol. 2, 11–19 (2002).
  CAS Google Scholar
• Raulet, D. H., Vance, R. E. & McMahon, C. W. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19, 291–330 (2001).
  CAS PubMed Google Scholar
• Karre, K., Ljunggren, H. G., Piontek, G. & Kiessling, R. Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675–678 (1986).
  CAS PubMed Google Scholar
• Tay, C. H., Szomolanyi-Tsuda, E. & Welsh, R. M. Control of infections by NK cells. Curr. Top. Microbiol. Immunol. 230, 193–220 (1998).
  CAS PubMed Google Scholar
• Yu, Y. Y., Kumar, V. & Bennett, M. Murine natural killer cells and marrow graft rejection. Annu. Rev. Immunol. 10, 189–213 (1992).
  CAS PubMed Google Scholar
• Lanier, L. L. NK cell recognition. Annu. Rev. Immunol. 23, 225–274 (2005).
  CAS PubMed Google Scholar
• Vance, R. E., Kraft, J. R., Altman, J. D., Jensen, P. E. & Raulet, D. H. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1b. J. Exp. Med. 188, 1841–1848 (1998).
  CAS PubMed PubMed Central Google Scholar
• Lee, N. et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl Acad. Sci. USA 95, 5199–5204 (1998).
  CAS PubMed PubMed Central Google Scholar
• Braud, V. M. et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391, 795–799 (1998).
  CAS PubMed Google Scholar
• Chapman, T. L., Heikeman, A. P. & Bjorkman, P. J. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11, 603–613 (1999).
  CAS PubMed Google Scholar
• Liao, N. S., Bix, M., Zijlstra, M., Jaenisch, R. & Raulet, D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253, 199–202 (1991).
  CAS PubMed Google Scholar
• Hoglund, P. et al. Recognition of β2-microglobulin-negative (β2m−) T-cell blasts by natural killer cells from normal but not from β2m− mice: nonresponsiveness controlled by β2m− bone marrow in chimeric mice. Proc. Natl Acad. Sci. USA 88, 10332–10336 (1991).
  CAS PubMed PubMed Central Google Scholar
• de la Salle, H. et al. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 265, 237–241 (1994).
  CAS PubMed Google Scholar
• Zimmer, J. et al. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J. Exp. Med. 187, 117–122 (1998).
  CAS PubMed PubMed Central Google Scholar
• Dorfman, J. R., Zerrahn, J., Coles, M. C. & Raulet, D. H. The basis for self-tolerance of natural killer cells in β2-microglobulin− and TAP-1− mice. J. Immunol. 159, 5219–5225 (1997).
  CAS PubMed Google Scholar
• Salcedo, M. et al. Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I-deficient mice. Eur. J. Immunol. 28, 1315–1321 (1998).
  CAS PubMed Google Scholar
• Markel, G. et al. The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients. Blood 103, 1770–1778 (2004). This study shows that increased CEACAM1 expression prevents NK-cell autoreactivity in TAP2-deficient patients.
  CAS PubMed Google Scholar
• Vitale, M. et al. Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells. Blood 99, 1723–1729 (2002). This paper shows that triggering receptors in TAP2-deficient patients are functional, and the authors suggest a role for non-MHC-binding inhibitory receptors in self-tolerance.
  CAS PubMed Google Scholar
• Furukawa, H., Iizuka, K., Poursine-Laurent, J., Shastri, N. & Yokoyama, W. M. A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from β2-microglobulin-deficient mice. J. Immunol. 169, 126–136 (2002).
  CAS PubMed Google Scholar
• Fernandez, N. C. et al. A subset of natural killer cells achieve self-tolerance without expressing inhibitory receptors specific for self MHC molecules. Blood 22 Feb 2005 (10.1182/blood-2004-1108-3156).
  Google Scholar
• Yu, Y. Y. et al. The role of Ly49A and 5E6 (Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. Immunity 4, 67–76 (1996).
  CAS PubMed Google Scholar
• Liu, J. et al. Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants. J. Immunol. 164, 1793–1799 (2000).
  CAS PubMed Google Scholar
• Sivakumar, P. V. et al. Expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49− cells: a possible mechanism of tolerance during NK cell development. J. Immunol. 162, 6976–6980 (1999).
  CAS PubMed Google Scholar
• Dorfman, J. R. & Raulet, D. H. Acquisition of Ly49 receptor expression by developing natural killer cells. J. Exp. Med. 187, 609–618 (1998).
  CAS PubMed PubMed Central Google Scholar
• Vance, R. E., Jamieson, A. M., Cado, D. & Raulet, D. H. Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation. Proc. Natl Acad. Sci. USA 99, 868–873 (2002).
  CAS PubMed PubMed Central Google Scholar
• Sivori, S. et al. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc. Natl Acad. Sci. USA 99, 4526–4531 (2002).
  CAS PubMed PubMed Central Google Scholar
• Lee, K. M. et al. 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J. Exp. Med. 199, 1245–1254 (2004). This paper, together with references 38 and 39, characterizes 2B4-deficient mice, showing that 2B4 inhibits NK cells and that this outcome is not regulated by SAP.
  CAS PubMed PubMed Central Google Scholar
• Boles, K. S., Stepp, S. E., Bennett, M., Kumar, V. & Mathew, P. A. 2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes. Immunol. Rev. 181, 234–249 (2001).
  CAS PubMed Google Scholar
• Kubota, K. A structurally variant form of the 2B4 antigen is expressed on the cell surface of mouse mast cells. Microbiol. Immunol. 46, 589–592 (2002).
  CAS PubMed Google Scholar
• Munitz, A. et al. 2B4 (CD244) is expressed and functional on human eosinophils. J. Immunol. 174, 110–118 (2005).
  CAS PubMed Google Scholar
• McNerney, M. E., Lee, K. M. & Kumar, V. 2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells. Mol. Immunol. 42, 489–494 (2005).
  CAS PubMed Google Scholar
• Engel, P., Eck, M. J. & Terhorst, C. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. Nature Rev. Immunol. 3, 813–821 (2003).
  CAS Google Scholar
• Brown, M. H. et al. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J. Exp. Med. 188, 2083–2090 (1998).
  CAS PubMed PubMed Central Google Scholar
• Valiante, N. M. & Trinchieri, G. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J. Exp. Med. 178, 1397–1406 (1993).
  CAS PubMed Google Scholar
• Garni-Wagner, B. A., Purohit, A., Mathew, P. A., Bennett, M. & Kumar, V. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J. Immunol. 151, 60–70 (1993).
  CAS PubMed Google Scholar
• Mooney, J. M. et al. The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression. J. Immunol. 173, 3953–3961 (2004).
  CAS PubMed Google Scholar
• Vaidya, S. V. et al. Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells. J. Immunol. 174, 800–807 (2005).
  CAS PubMed Google Scholar
• Lee, K. M. et al. The NK cell receptor 2B4 augments antigen-specific T cell cytotoxicity through CD48 ligation on neighboring T cells. J. Immunol. 170, 4881–4885 (2003).
  CAS PubMed Google Scholar
• Assarsson, E. et al. NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions. J. Immunol. 173, 174–180 (2004).
  CAS PubMed Google Scholar
• Kambayashi, T., Assarsson, E., Chambers, B. J. & Ljunggren, H. G. Regulation of CD8+ T cell proliferation by 2B4/CD48 interactions. J. Immunol. 167, 6706–6710 (2001).
  CAS PubMed Google Scholar
• Tangye, S. G., Phillips, J. H., Lanier, L. L. & Nichols, K. E. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J. Immunol. 165, 2932–2936 (2000).
  CAS PubMed Google Scholar
• Tangye, S. G., Cherwinski, H., Lanier, L. L. & Phillips, J. H. 2B4-mediated activation of human natural killer cells. Mol. Immunol. 37, 493–501 (2000).
  CAS PubMed Google Scholar
• Parolini, S. et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein–Barr virus-infected cells. J. Exp. Med. 192, 337–346 (2000).
  CAS PubMed PubMed Central Google Scholar
• Glimcher, L., Shen, F. W. & Cantor, H. Identification of a cell-surface antigen selectively expressed on the natural killer cell. J. Exp. Med. 145, 1–9 (1977).
  CAS PubMed Google Scholar
• Koo, G. C. & Peppard, J. R. Establishment of monoclonal anti-NK-1.1 antibody. Hybridoma 3, 301–303 (1984).
  CAS PubMed Google Scholar
• Arase, N. et al. Association with FcRγ is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1.1+ T cells. J. Exp. Med. 186, 1957–1963 (1997).
  CAS PubMed PubMed Central Google Scholar
• Carlyle, J. R. et al. Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function. J. Immunol. 162, 5917–5923 (1999).
  CAS PubMed Google Scholar
• Kung, S. K., Su, R. C., Shannon, J. & Miller, R. G. The NKR-P1B gene product is an inhibitory receptor on SJL/J NK cells. J. Immunol. 162, 5876–5887 (1999).
  CAS PubMed Google Scholar
• Iizuka, K., Naidenko, O. V., Plougastel, B. F., Fremont, D. H. & Yokoyama, W. M. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nature Immunol. 4, 801–807 (2003).
  CAS Google Scholar
• Carlyle, J. R. et al. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc. Natl Acad. Sci. USA 101, 3527–3532 (2004). References 51 and 52 identify CLRs as ligands for receptors of the NKR-P1 family.
  CAS PubMed PubMed Central Google Scholar
• Lanier, L. L., Chang, C. & Phillips, J. H. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J. Immunol. 153, 2417–2428 (1994).
  CAS PubMed Google Scholar
• Yokoyama, W. M. & Plougastel, B. F. Immune functions encoded by the natural killer gene complex. Nature Rev. Immunol. 3, 304–316 (2003).
  CAS Google Scholar
• Zhou, H. et al. A novel osteoblast-derived C-type lectin that inhibits osteoclast formation. J. Biol. Chem. 276, 14916–14923 (2001).
  CAS PubMed Google Scholar
• Plougastel, B., Dubbelde, C. & Yokoyama, W. M. Cloning of Clr, a new family of lectin-like genes localized between mouse Nkrp1a and Cd69. Immunogenetics 53, 209–214 (2001).
  CAS PubMed Google Scholar
• Boles, K. S., Barten, R., Kumaresan, P. R., Trowsdale, J. & Mathew, P. A. Cloning of a new lectin-like receptor expressed on human NK cells. Immunogenetics 50, 1–7 (1999).
  CAS PubMed Google Scholar
• Mathew, P. A. et al. The LLT1 receptor induces IFN-γ production by human natural killer cells. Mol. Immunol. 40, 1157–1163 (2004).
  CAS PubMed Google Scholar
• Hammarstrom, S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin. Cancer Biol. 9, 67–81 (1999).
  CAS PubMed Google Scholar
• Moller, M. J., Kammerer, R., Grunert, F. & von Kleist, S. Biliary glycoprotein (BGP) expression on T cells and on a natural-killer-cell sub-population. Int. J. Cancer 65, 740–745 (1996).
  CAS PubMed Google Scholar
• Markel, G. et al. The critical role of residues 43R and 44Q of carcinoembryonic antigen cell adhesion molecules-1 in the protection from killing by human NK cells. J. Immunol. 173, 3732–3739 (2004).
  CAS PubMed Google Scholar
• Singer, B. B. et al. Carcinoembryonic antigen-related cell adhesion molecule 1 expression and signaling in human, mouse, and rat leukocytes: evidence for replacement of the short cytoplasmic domain isoform by glycosylphosphatidylinositol-linked proteins in human leukocytes. J. Immunol. 168, 5139–5146 (2002).
  CAS PubMed Google Scholar
• Kammerer, R., Stober, D., Singer, B. B., Obrink, B. & Reimann, J. Carcinoembryonic antigen-related cell adhesion molecule 1 on murine dendritic cells is a potent regulator of T cell stimulation. J. Immunol. 166, 6537–6544 (2001).
  CAS PubMed Google Scholar
• Markel, G. et al. CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity. J. Immunol. 168, 2803–2810 (2002). This was one of the first reports on the inhibition of NK cells by CEACAM1, which led to much further research.
  CAS PubMed Google Scholar
• Markel, G. et al. Biological function of the soluble CEACAM1 protein and implications in TAP2-deficient patients. Eur. J. Immunol. 34, 2138–2148 (2004).
  CAS PubMed Google Scholar
• Svenberg, T. et al. Serum level of biliary glycoprotein I, a determinant of cholestasis, of similar use as γ-glutamyltranspeptidase. Scand. J. Gastroenterol. 16, 817–824 (1981).
  CAS PubMed Google Scholar
• Crocker, P. R. & Varki, A. Siglecs, sialic acids and innate immunity. Trends Immunol. 22, 337–342 (2001).
  CAS PubMed Google Scholar
• Angata, T. & Varki, A. Chemical diversity in the sialic acids and related _α_-keto acids: an evolutionary perspective. Chem. Rev. 102, 439–469 (2002).
  CAS PubMed Google Scholar
• Falco, M. et al. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. J. Exp. Med. 190, 793–802 (1999).
  CAS PubMed PubMed Central Google Scholar
• Nicoll, G. et al. Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes. J. Biol. Chem. 274, 34089–34095 (1999).
  CAS PubMed Google Scholar
• Ito, A., Handa, K., Withers, D. A., Satoh, M. & Hakomori, S. Binding specificity of siglec7 to disialogangliosides of renal cell carcinoma: possible role of disialogangliosides in tumor progression. FEBS Lett. 504, 82–86 (2001).
  CAS PubMed Google Scholar
• Yamaji, T., Teranishi, T., Alphey, M. S., Crocker, P. R. & Hashimoto, Y. A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to _α_2,8-disialyl and branched α2,6-sialyl residues. A comparison with Siglec-9. J. Biol. Chem. 277, 6324–6332 (2002).
  CAS PubMed Google Scholar
• Nicoll, G. et al. Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms. Eur. J. Immunol. 33, 1642–1648 (2003). This paper shows that GD3 expression by target cells inhibits NK cells through interaction with SIGLEC7.
  CAS PubMed Google Scholar
• Urmacher, C., Cordon-Cardo, C. & Houghton, A. N. Tissue distribution of GD3 ganglioside detected by mouse monoclonal antibody R24. Am. J. Dermatopathol. 11, 577–581 (1989).
  CAS PubMed Google Scholar
• Kniep, B., Flegel, W. A., Northoff, H. & Rieber, E. P. CDw60 glycolipid antigens of human leukocytes: structural characterization and cellular distribution. Blood 82, 1776–1786 (1993).
  CAS PubMed Google Scholar
• Ikehara, Y., Ikehara, S. K. & Paulson, J. C. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9. J. Biol. Chem. 279, 43117–43125 (2004).
  CAS PubMed Google Scholar
• Avril, T., Floyd, H., Lopez, F., Vivier, E. & Crocker, P. R. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by siglecs-7 and -9, CD33-related siglecs expressed on human monocytes and NK cells. J. Immunol. 173, 6841–6849 (2004).
  CAS PubMed Google Scholar
• Zhang, J. Q., Nicoll, G., Jones, C. & Crocker, P. R. Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes. J. Biol. Chem. 275, 22121–22126 (2000).
  CAS PubMed Google Scholar
• Zhang, J. Q., Biedermann, B., Nitschke, L. & Crocker, P. R. The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils. Eur. J. Immunol. 34, 1175–1184 (2004).
  CAS PubMed Google Scholar
• Ulyanova, T., Shah, D. D. & Thomas, M. L. Molecular cloning of MIS, a myeloid inhibitory siglec, that binds protein-tyrosine phosphatases SHP-1 and SHP-2. J. Biol. Chem. 276, 14451–14458 (2001).
  CAS PubMed Google Scholar
• van den Berg, T. K., Yoder, J. A. & Litman, G. W. On the origins of adaptive immunity: innate immune receptors join the tale. Trends Immunol. 25, 11–16 (2004).
  CAS PubMed Google Scholar
• Piccio, L. et al. Adhesion of human T cells to antigen-presenting cells through SIRPβ2–CD47 interaction costimulates T cell proliferation. Blood 105, 2421–2427 (2005).
  CAS PubMed Google Scholar
• Brooke, G., Holbrook, J. D., Brown, M. H. & Barclay, A. N. Human lymphocytes interact directly with CD47 through a novel member of the signal regulatory protein (SIRP) family. J. Immunol. 173, 2562–2570 (2004).
  CAS PubMed Google Scholar
• Oldenborg, P. -A. et al. Role of CD47 as a marker of self on red blood cells. Science 288, 2051–2054 (2000).
  CAS PubMed Google Scholar
• Blazar, B. R. et al. CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells. J. Exp. Med. 194, 541–550 (2001).
  CAS PubMed PubMed Central Google Scholar
• Katz, H. R. Inhibitory receptors and allergy. Curr. Opin. Immunol. 14, 698–704 (2002).
  CAS PubMed Google Scholar
• Wang, L. L., Mehta, I. K., LeBlanc, P. A. & Yokoyama, W. M. Mouse natural killer cells express gp49B1, a structural homologue of human killer inhibitory receptors. J. Immunol. 158, 13–17 (1997).
  CAS PubMed Google Scholar
• Wang, L. L., Chu, D. T., Dokun, A. O. & Yokoyama, W. M. Inducible expression of the gp49B inhibitory receptor on NK cells. J. Immunol. 164, 5215–5220 (2000).
  CAS PubMed Google Scholar
• Castells, M. C. et al. gp49B1–αvβ3 interaction inhibits antigen-induced mast cell activation. Nature Immunol. 2, 436–442 (2001).
  CAS Google Scholar
• Wilder, R. L. Integrin αVβ3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases. Ann. Rheum. Dis. 61, ii96–ii99 (2002).
  CAS PubMed PubMed Central Google Scholar
• Rojo, S. et al. Natural killer cells and mast cells from gp49B null mutant mice are functional. Mol. Cell. Biol. 20, 7178–7182 (2000).
  CAS PubMed PubMed Central Google Scholar
• Gu, X. et al. The gp49B1 inhibitory receptor regulates the IFN-γ responses of T cells and NK cells. J. Immunol. 170, 4095–4101 (2003). This study shows that, compared with cells from normal mice, gp49B1-deficient NK cells and T cells produce more IFN-γ ex vivo , following in vivo viral infection.
  CAS PubMed Google Scholar
• Abramson, J., Xu, R. & Pecht, I. An unusual inhibitory receptor — the mast cell function-associated antigen (MAFA). Mol. Immunol. 38, 1307–1313 (2002).
  CAS PubMed Google Scholar
• Robbins, S. H. et al. Inhibitory functions of the killer cell lectin-like receptor G1 molecule during the activation of mouse NK cells. J. Immunol. 168, 2585–2589 (2002).
  CAS PubMed Google Scholar
• Corral, L., Hanke, T., Vance, R. E., Cado, D. & Raulet, D. H. NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules. Eur. J. Immunol. 30, 920–930 (2000).
  CAS PubMed Google Scholar
• Meyaard, L. et al. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 7, 283–290 (1997).
  CAS PubMed Google Scholar
• Thorley-Lawson, D. A., Schooley, R. T., Bhan, A. K. & Nadler, L. M. Epstein–Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts. Cell 30, 415–425 (1982).
  CAS PubMed Google Scholar
• Biron, C. A., Byron, K. S. & Sullivan, J. L. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320, 1731–1735 (1989).
  CAS PubMed Google Scholar
• Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B. & Lanier, L. L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296, 1323–1326 (2002).
  CAS PubMed Google Scholar
• Afonso, C. L. et al. The genome of fowlpox virus. J. Virol. 74, 3815–3831 (2000).
  CAS PubMed PubMed Central Google Scholar
• Shchelkunov, S. N. et al. The genomic sequence analysis of the left and right species-specific terminal region of a cowpox virus strain reveals unique sequences and a cluster of intact ORFs for immunomodulatory and host range proteins. Virology 243, 432–460 (1998).
  CAS PubMed Google Scholar
• Wilcock, D., Duncan, S. A., Traktman, P., Zhang, W. H. & Smith, G. L. The vaccinia virus A4OR gene product is a nonstructural, type II membrane glycoprotein that is expressed at the cell surface. J. Gen. Virol. 80, 2137–2148 (1999).
  CAS PubMed Google Scholar
• Cameron, C. et al. The complete DNA sequence of myxoma virus. Virology 264, 298–318 (1999).
  CAS PubMed Google Scholar
• Neilan, J. G. et al. An African swine fever virus ORF with similarity to C-type lectins is non-essential for growth in swine macrophages in vitro and for virus virulence in domestic swine. J. Gen. Virol. 80, 2693–2697 (1999).
  CAS PubMed Google Scholar
• Voigt, S., Sandford, G. R., Ding, L. & Burns, W. H. Identification and characterization of a spliced C-type lectin-like gene encoded by rat cytomegalovirus. J. Virol. 75, 603–611 (2001).
  CAS PubMed PubMed Central Google Scholar
• Lindberg, F. P., Gresham, H. D., Schwarz, E. & Brown, E. J. Molecular cloning of integrin-associated protein: an immunoglobulin family member with multiple membrane-spanning domains implicated in αVβ3-dependent ligand binding. J. Cell Biol. 123, 485–496 (1993).
  CAS PubMed Google Scholar
• Campbell, I. G., Freemont, P. S., Foulkes, W. & Trowsdale, J. An ovarian tumor marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains. Cancer Res. 52, 5416–5420 (1992).
  CAS PubMed Google Scholar
• Tseng, C. T. & Klimpel, G. R. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 195, 43–49 (2002).
  CAS PubMed PubMed Central Google Scholar
• Crotta, S. et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 195, 35–41 (2002).
  CAS PubMed PubMed Central Google Scholar
• Razi, N. & Varki, A. Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation. Glycobiology 9, 1225–1234 (1999).
  CAS PubMed Google Scholar
• Razi, N. & Varki, A. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. Proc. Natl Acad. Sci. USA 95, 7469–7474 (1998).
  CAS PubMed PubMed Central Google Scholar
• Boulton, I. C. & Gray-Owen, S. D. Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes. Nature Immunol. 3, 229–236 (2002). This paper shows that the binding of bacteria to CEACAM1 at the surface of T cells inhibits T-cell functions.
  CAS Google Scholar
• Dveksler, G. S. et al. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J. Virol. 67, 1–8 (1993).
  CAS PubMed PubMed Central Google Scholar
• Virji, M., Watt, S. M., Barker, S., Makepeace, K. & Doyonnas, R. The N-domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae. Mol. Microbiol. 22, 929–939 (1996).
  CAS PubMed Google Scholar
• Leusch, H. G., Drzeniek, Z., Markos-Pusztai, Z. & Wagener, C. Binding of Escherichia coli and Salmonella strains to members of the carcinoembryonic antigen family: differential binding inhibition by aromatic α-glycosides of mannose. Infect. Immun. 59, 2051–2057 (1991).
  CAS PubMed PubMed Central Google Scholar
• Hill, D. J. & Virji, M. A novel cell-binding mechanism of Moraxella catarrhalis ubiquitous surface protein UspA: specific targeting of the N-domain of carcinoembryonic antigen-related cell adhesion molecules by UspA1. Mol. Microbiol. 48, 117–129 (2003).
  CAS PubMed Google Scholar
• Virji, M. et al. Carcinoembryonic antigens are targeted by diverse strains of typable and non-typable Haemophilus influenzae. Mol. Microbiol. 36, 784–795 (2000).
  CAS PubMed Google Scholar
• Garrido, F. et al. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol. Today 18, 89–95 (1997).
  CAS PubMed Google Scholar
• Demanet, C. et al. Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack? Blood 103, 3122–3130 (2004).
  CAS PubMed Google Scholar
• Saito, S. et al. Expression of globe-series gangliosides in human renal cell carcinoma. Jpn J. Cancer Res. 88, 652–659 (1997).
  CAS PubMed PubMed Central Google Scholar
• Plunkett, T. A. & Ellis, P. A. CEACAM1: a marker with a difference or more of the same? J. Clin. Oncol. 20, 4273–4275 (2002).
  PubMed Google Scholar
• Thies, A. et al. CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease. J. Clin. Oncol. 20, 2530–2536 (2002).
  CAS PubMed Google Scholar
• Laack, E. et al. Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance. J. Clin. Oncol. 20, 4279–4284 (2002).
  PubMed Google Scholar
• Kammerer, R. et al. The tumour suppressor gene CEACAM1 is completely but reversibly downregulated in renal cell carcinoma. J. Pathol. 204, 258–267 (2004).
  CAS PubMed Google Scholar
• Pende, D. et al. Analysis of the receptor–ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the poliovirus receptor (CD155) and nectin-2 (CD112). Blood 105, 2066–2073 (2005).
  CAS PubMed Google Scholar
• Ruggeri, L. et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295, 2097–2100 (2002). This study shows the clinical benefits of NK-cell alloreactivity.
  CAS PubMed Google Scholar
• Moffett-King, A. Natural killer cells and pregnancy. Nature Rev. Immunol. 2, 656–663 (2002).
  CAS Google Scholar
• Markel, G. et al. Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions. J. Clin. Invest. 110, 943–953 (2002).
  CAS PubMed PubMed Central Google Scholar
• Blazar, B. R. et al. A critical role for CD48 antigen in regulating alloengraftment and lymphohematopoietic recovery after bone marrow transplantation. Blood 92, 4453–4463 (1998).
  CAS PubMed Google Scholar
• Vitale, C. et al. Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation. Eur. J. Immunol. 34, 455–460 (2004).
  CAS PubMed Google Scholar
• Smith, G. M., Biggs, J., Norris, B., Anderson-Stewart, P. & Ward, R. Detection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthritis. J. Clin. Immunol. 17, 502–509 (1997).
  CAS PubMed Google Scholar
• Wandstrat, A. E. et al. Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity 21, 769–780 (2004).
  CAS PubMed Google Scholar
• Speckman, R. A. et al. Novel immunoglobulin superfamily gene cluster, mapping to a region of human chromosome 17q25, linked to psoriasis susceptibility. Hum. Genet. 112, 34–41 (2003).
  CAS PubMed Google Scholar
• Cantoni, C. et al. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur. J. Immunol. 29, 3148–3159 (1999).
  CAS PubMed Google Scholar
• Iijima, H. et al. Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1. J. Exp. Med. 199, 471–482 (2004).
  CAS PubMed PubMed Central Google Scholar
• Boulanger, L. M. & Shatz, C. J. Immune signalling in neural development, synaptic plasticity and disease. Nature Rev. Neurosci. 5, 521–531 (2004).
  CAS Google Scholar
• Malisan, F. & Testi, R. GD3 ganglioside and apoptosis. Biochim. Biophys. Acta 1585, 179–187 (2002).
  CAS PubMed Google Scholar
• Backstrom, E., Chambers, B. J., Kristensson, K. & Ljunggren, H. G. Direct NK cell-mediated lysis of syngenic dorsal root ganglia neurons in vitro. J. Immunol. 165, 4895–4900 (2000).
  CAS PubMed Google Scholar